Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
SLS

SELLAS Life Sciences Group, Inc. (SLS)

NASDAQ
$17.94
-$1.20
(-6.29%)
Previous Close: ⁦$19.15⁩
Market Closed

Last updated: ⁦2026-11-19 02:28:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

SELLAS Life Sciences Group, Inc. (SLS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $17.94, with a market capitalization of $1.52B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.39 to $24.89. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$1.52B

$19.51

$21.34

$17.00

$19.15

34.80M

8.77M

--

$24.89

$1.39

--

2026-09-30

SELLAS Life Sciences Group, Inc. (SLS) Latest Closing Stock Price

SELLAS Life Sciences Group, Inc. (SLS) last closed at $17.94 as of 2026-11-19 01:00:00, down 6.29% ($1.20) from the previous close of $19.15.

During the latest regular trading session, SLS traded between $17.00 and $21.34, with a volume of 34.80M shares. The closing price was near the lower end and near the upper end of its 52-week range.

Why Is SLS Stock Down Today?

SLS is down 0.37% as of the last close.

SELLAS Life Sciences shares are trading higher after the company announced topline results from its phase 3 REGAL trial evaluating galinpepimut-S in patients with acute myeloid leukemia met its primary endpoint.

Source: Benzinga · Updated

SELLAS Life Sciences Group, Inc. (SLS) 7-Day Stock Price Change

Over the past seven days, SELLAS Life Sciences Group, Inc. (SLS) moved from $8.58 to $17.94, representing a gain of 109.14% ($9.36).

The stock traded between $7.24 and $24.89 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 22.35 million shares, up versus the previous seven-day period, indicating higher trading activity.

SLS 52-Week Price Position

Position in Range: 70.4%

52W Low$1.39
52W High$24.89

SLS is currently trading at $17.94, placing it 70.4% of the way from its 52-week low of $1.39 to its 52-week high of $24.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is SELLAS Life Sciences Group, Inc. (SLS)?

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

SELLAS Life Sciences Group, Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
13
CEO
Angelos M. Stergiou
Exchange
NASDAQ
Company Website

SLS Stock Events

View the latest dividend and stock split events for SELLAS Life Sciences Group, Inc.

Dividend
Ex-Dividend DateMar 24, 2011
Payment DateApr 5, 2011
Dividend Per Share$0.2403

SLS News

Latest news related to SELLAS Life Sciences Group, Inc. and SLS stock.

  • Benzinga

    Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of FOMC Minutes— NVDA, AAOI, PANW in Focus (UPDATED)

    U.S. stocks rose on Wednesday, as the Dow Jones, S&P 500, and Nasdaq 100 index futures advanced, following Tuesday's lower close.

    Read Full Article
  • Benzinga

    Dolby Laboratories, Jumia Technologies, Applied Optoelectronics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

    Dolby slid on below-estimate FY27 guidance, while Red Cat, Jumia, BGIN and other stocks declined in premarket trading.

    Read Full Article
  • Benzinga

    Why Pony AI Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

    Pony AI rose 10.6% after beating Q3 loss estimates but missing sales; Autozi led gainers, while IRIDEX fell 17.6% on results and guidance.

    Read Full Article
  • Massive

    SELLAS anuncia resultados positivos del ensayo pivotal de fase 3 REGAL, que demuestran que la vacuna inmunoterapéutica contra el cáncer galinpepimut-S (GPS) produjo una mejora estadísticamente significativa y clínicamente relevante de la supervivencia global en pacientes con leucemia mieloide aguda

    SELLAS Life Sciences announced positive results from its Phase 3 REGAL trial showing that galinpepimut-S (GPS), an immunotherapeutic cancer vaccine, demonstrated a statistically significant 41% reduction in risk of death in acute myeloid leukemia patients, with median overall survival of 24.0 months versus 14.7 months with standard treatment. The company plans to meet with the FDA and submit a biologics license application in the first half of 2027.

    Read Full Article
  • Massive

    SELLAS Life Sciences Divulga Dados Positivos do Estudo REGAL Pivotal de Fase 3, Indicando que Galinpepimut-S (GPS), a Vacina Imunoterapêutica Contra o Câncer, Demonstrou uma Melhora Estatisticamente Significativa e Clinicamente Relevante na Sobrevida Global de Pacientes com Leucemia Mieloide Aguda

    SELLAS Life Sciences announced positive Phase 3 REGAL trial results for its immunotherapeutic cancer vaccine Galinpepimut-S (GPS) in acute myeloid leukemia patients. GPS demonstrated a statistically significant 41% reduction in death risk with median overall survival of 24.0 months versus 14.7 months for best available treatment (p=0.035). The company plans to meet with the FDA and submit a Biologics License Application in the first half of 2027.

    Read Full Article

Ways to Trade SLS at MEXC

SLS MEXC RealStocks

Own real SLS shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

SLS Tokenized Stocks

Get SLS price exposure through a blockchain-based token.


Suitable for trading outside U.S. market hours.

  • Token tracks the SLS price
  • Trade 24/7
  • Trade on weekends and holidays

SLS Stock Futures

Trade SLS price movements with futures contracts.


Suitable for short-term positions.

  • Go long or short
  • Trade 24/7
  • Up to 20x leverage

How to Buy SELLAS Life Sciences Group, Inc. (SLS) Stock on MEXC

Eligible investors can buy real shares of SELLAS Life Sciences Group, Inc. (SLS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for SLS and Place Your Order
Step 3: Search for SLS and Place Your Order
Open the RealStocks trading page and search for SLS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is SELLAS Life Sciences Group, Inc. (SLS) stock price today?
SELLAS Life Sciences Group, Inc. (SLS) is currently trading at $17.94, down 6.29% ($1.20) from the previous close of $19.15. Intraday prices update in real time during regular trading hours.
2.Is SLS stock going up or down today?
As of 2026-11-19 01:00:00, SLS is trading at $17.94, down 6.29% ($1.20) from its previous close of $19.15. The stock has traded between $17.00 and $21.34 during today’s regular session. Past price movements do not guarantee future results.
3.What is SLS pre-market price?
As of 2026-11-19 01:00:00, SLS is trading at $19.13 in pre-market trading, down 0.08% ($0.02) from the previous close of $19.15. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is SLS after-hours price?
As of 2026-11-19 01:00:00, SLS is trading at $17.95 in after-hours trading, up 0.03% ($0.01) from the regular-session close of $17.94. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is SLS stock trading now?
SLS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does SLS sit relative to its 52-week high and low?
Over the past 52 weeks, SLS has traded between a low of $1.39 and a high of $24.89. At $17.94, the stock is positioned 70.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is SELLAS Life Sciences Group, Inc. in?
SELLAS Life Sciences Group, Inc. (SLS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is SELLAS Life Sciences Group, Inc.'s market capitalization and where is it listed?
SELLAS Life Sciences Group, Inc. is listed on the NASDAQ exchange with a market capitalization of $1.52B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is SLS valued in terms of P/E ratio and EPS?
SLS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-0.18. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does SELLAS Life Sciences Group, Inc. pay a dividend?
SELLAS Life Sciences Group, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SLS, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

SLS Stock Calculator

Estimate the value between SLS shares and USD.

SLS Shares to USD

SLS Shares
SLS
SLS
USD
USD
USD

1.00 SLS shares = 17.944 USD

Calculations are estimates based on the latest available price and are for reference only.